Novo Nordisk A/S

NYSE:NVO Stock Report

Market Cap: US$556.4b

Novo Nordisk Management

Management criteria checks 4/4

Novo Nordisk's CEO is Lars Jorgensen, appointed in Jan 2017, has a tenure of 7.25 years. total yearly compensation is DKK60.10M, comprised of 28.5% salary and 71.5% bonuses, including company stock and options. directly owns 0.002% of the company’s shares, worth $11.57M. The average tenure of the management team and the board of directors is 3.2 years and 6.1 years respectively.

Key information

Lars Jorgensen

Chief executive officer

kr.60.1m

Total compensation

CEO salary percentage28.5%
CEO tenure7.3yrs
CEO ownership0.002%
Management average tenure3.2yrs
Board average tenure6.1yrs

Recent management updates

No updates

Recent updates

Novo Nordisk: Medicare Coverage To Unlock Another Big Market For Wegovy

Apr 26

Novo Nordisk: The Moat Won't Last Forever

Apr 09

Shaping The Future Of Obesity Treatment: GLP-1 Agonists At The Forefront

Mar 18

Novo Nordisk: My 'Hold' Thesis For 2024 - The Premium Must Be Justified

Mar 07

Novo Nordisk, A Very Healthy Pharma Stalwart

Feb 28

Novo Nordisk: SOTP After Impressive FY23 And Weight Loss Going Mainstream, Maintain Buy

Feb 23

Novo Nordisk: Irrational Exuberance Isn't Worth The Risk

Feb 16

Novo Nordisk: Outlook For Weight Loss Drugs In 2024

Jan 22

Taking Novo Nordisk To The Next Level

Jan 15

Profiting From Obesity Drugs HRTS, Novo Nordisk And Eli Lilly

Jan 02

Novo Nordisk: Latest Insights Confirm Exceptionally Bullish Opportunity

Dec 12

Novo Nordisk: Eli Lilly's Zepbound Approval Is Not A Threat To Valuation

Nov 24

Novo Nordisk: Growing To Potentially Become The First Trillion-Dollar European Champion

Oct 24

Novo Nordisk: Catching The Falling Knife Now Could Really Hurt

Sep 22

Novo Nordisk: Strong Fundamentals Meet Technical Uptrends

Aug 30

Novo Nordisk: Denmark's Coca-Cola

Jul 25

The Case For Novo Nordisk: Growth, Dividends, And A New Treatment Frontier

Jul 11

Novo Nordisk Is A Hold Despite Explosive Growth In Diabetes And Obesity Care

Jun 23

Novo Nordisk: Dominating In Diabetes And Obesity

Jun 05

Novo Nordisk: Flourishing Financials And Emerging Opportunities In Diabetes And Obesity

May 23

Novo Nordisk: Attractive Market But Likely No Margin Of Safety

Feb 15

Novo Nordisk to sell Wegovy in bigger European markets -- Bloomberg

Feb 07

Novo Nordisk FY 2022 Earnings Preview

Jan 31

Novo Nordisk says FDA updated label for oral diabetes therapy Rybelsus

Jan 13

CEO Compensation Analysis

How has Lars Jorgensen's remuneration changed compared to Novo Nordisk's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

kr.84b

Sep 30 2023n/an/a

kr.75b

Jun 30 2023n/an/a

kr.67b

Mar 31 2023n/an/a

kr.61b

Dec 31 2022kr.60mkr.17m

kr.56b

Sep 30 2022n/an/a

kr.53b

Jun 30 2022n/an/a

kr.51b

Mar 31 2022n/an/a

kr.49b

Dec 31 2021kr.58mkr.17m

kr.48b

Sep 30 2021n/an/a

kr.46b

Jun 30 2021n/an/a

kr.44b

Mar 31 2021n/an/a

kr.43b

Dec 31 2020kr.57mkr.14m

kr.42b

Sep 30 2020n/an/a

kr.42b

Jun 30 2020n/an/a

kr.41b

Mar 31 2020n/an/a

kr.40b

Dec 31 2019kr.55mkr.14m

kr.39b

Sep 30 2019n/an/a

kr.39b

Jun 30 2019n/an/a

kr.38b

Mar 31 2019n/an/a

kr.38b

Dec 31 2018kr.41mkr.11m

kr.39b

Sep 30 2018n/an/a

kr.38b

Jun 30 2018n/an/a

kr.39b

Mar 31 2018n/an/a

kr.39b

Dec 31 2017kr.32mkr.9m

kr.38b

Compensation vs Market: Lars's total compensation ($USD8.65M) is below average for companies of similar size in the US market ($USD13.53M).

Compensation vs Earnings: Lars's compensation has been consistent with company performance over the past year.

CEO

Lars Jorgensen (57 yo)

7.3yrs

Tenure

kr.60,100,000

Compensation

Mr. Lars Fruergaard Jorgensen serves as Director at Danmarks Nationalbank since April 2024. He has been Chief Executive Officer and President of Novo Nordisk A/S since January 2017and serves as its Member...

Leadership Team

NamePositionTenureCompensationOwnership
Lars Jorgensen
President7.3yrskr.60.10m0.0021%
DKK 11.6m
Karsten Knudsen
Executive VP6.2yrskr.21.50m0.000010%
DKK 55.6k
Henrik Wulff
Executive VP of Product Supplyno datakr.22.00m0.000060%
DKK 333.8k
Camilla Sylvest
Executive VP of Commercial Strategy & Corporate Affairs and Member of the Management Boardno datakr.21.30m0%
DKK 0
Martin Lange
Executive VP of Development & Member of the Management Board3.3yrskr.20.90mno data
Marcus Schindler
EVP of Research & Early Development3.1yrskr.20.90mno data
Maziar Doustdar
Executive VP of International Operations & Member of the Management Boardno datano data0.0024%
DKK 13.1m
Douglas Langa
Executive VP of North America Operations & Member of Management Boardno datano datano data
Ludovic Helfgott
Executive VPno datano datano data
Tania Sabroe
Executive VP of Global People & Organisation and Member of Management Board1.1yrsno datano data
David Moore
Executive VP of Corporate Development & Member of Management Board1.1yrsno datano data
Daniel Bohsen
CVP & Head of Investor Relationsno datano datano data

3.2yrs

Average Tenure

53yo

Average Age

Experienced Management: NVO's management team is considered experienced (3.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Sylvie Gregoire
Independent Director9.1yrskr.1.80mno data
Helge Lund
Independent Chairman of the Board7.1yrskr.3.10mno data
Henrik Poulsen
Vice Chairman of the Board3.1yrskr.2.00mno data
Laurence Debroux
Independent Director5.1yrskr.2.00mno data
Martin MacKay
Independent Director6.1yrskr.1.70mno data
Andreas Fibig
Independent Director6.1yrskr.1.40mno data
Kasim Kutay
Non-Independent Director7.1yrskr.1.20mno data
Christina Law
Independent Director2.1yrskr.1.30mno data
Liselotte Hyveled
Employee Representative Director2.1yrskr.800.00k0.00019%
DKK 1.1m
Mette Jensen
Employee Non-Independent Representative Director6.1yrskr.1.20mno data
Thomas Rantzau
Employee Representative Non-Independent Director6.3yrskr.1.00mno data
Elisabeth Christensen
Employee Representative Director2.1yrskr.800.00kno data

6.1yrs

Average Tenure

57.5yo

Average Age

Experienced Board: NVO's board of directors are considered experienced (6.1 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.